Form 4 · Filed Jul 16, 2026, 09:39 PM UTC
GALT/GALECTIN THERAPEUTICS INC
Jamil Khurram — Chief Medical Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | M | other | 16,250 | $3 | $49,400 | 16,250 |
| Jul 14, 2026 | S | sell | 16,250 | $5 | $83,285 | 0 |
| Jul 14, 2026 | M | other | 16,250 | — | — | 48,750 |
Source: SEC EDGAR raw filing ↗ · Accession 0001133416-26-000063